XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Stock-Based Compensation [Abstract]  
Schedule of Option Activity

The following table summarizes the Company’s option activity for the nine months ended September 30, 2025 (in thousands, except exercise price and contractual life data):

 

   Number
Outstanding
   Weighted
Average
Exercise
Price per
Share
   Weighted
Average
Remaining
Contractual Life (Years)
 
             
Balance as of December 31, 2024   12,983   $2.34    2.9 
Granted   1,455    10.76    4.5 
Exercised*   (7,168)   2.30    - 
Forfeited   (342)   8.10    - 
Balance as of September 30, 2025   6,928   $3.86    2.8 
Vested and exercisable as of September 30, 2025   3,512   $3.92    2.4 

 

* The difference of 1,815 compared to the condensed consolidated statement of stockholders equity amount of 5,353 is a result of the Company’s policy to allow net exercise of options.
Schedule of Grant-Date Fair Value of Stock Options Granted

The following table presents the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the three and nine months ended September 30, 2025 and 2024:

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Exercise price  $ 15.24 – 20.21   $ 1.00 – 1.12   $1.00 – 20.21   $1.00 – 1.12 
Risk-free interest rate   3.6 – 4.1%   5.2 – 5.2%   3.6 – 4.2%   5.2 – 5.2%
Expected volatility   133.0 – 136.5%   93.2 – 104.6%   130.0 – 138.0%   93.2 – 104.6%
Expected dividend yield   0%   0%   0%   0%
Expected life of options (in years)   5.0    5.0    5.0    5.0 
Schedule of Exercise Price Range

The following table summarizes the exercise price range as of September 30, 2025 (in thousands, except exercise price data):

 

Exercise Price  Outstanding Options   Exercisable Options 
$0.00 - $1.00   75    45 
$1.00 - $2.00   3,726    1,124 
$2.00 - $3.00   1,295    1,287 
$3.00 - $6.00   158    38 
$6.00 - $8.00   967    742 
$8.00 - $12.00   227    177 
$12.00 - $15.00   30    
-
 
$15.00 - $20.00   435    100 
$20.00 - $21.00   15    
-
 
    6,928    3,513 
Schedule of Activity for Restricted Stock The following table summarizes the Company’s activity for restricted stock tied to vesting schedules for the nine months ended September 30, 2025 (in thousands):
   Number
Outstanding
   Weighted
Average
Fair Value
 
         
Unvested as of December 31, 2024   1,264   $1.20 
Granted   
-
    
-
 
Vested   (130)   0.67 
Forfeited   (8)   0.67 
Unvested as of September 30, 2025   1,126   $0.75 
Schedule of Stock-Based Compensation Expense Related to Common Stock Options and Restricted Shares of Common Stock

The Company recognized stock-based compensation expense related to common stock options and restricted shares of common stock in the following expense categories of its condensed consolidated statements of operations (in thousands):

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Research and development  $526   $562   $1,490   $1,761 
Selling and marketing   62    12    153    123 
General and administrative   2,484    189    4,593    796 
Total stock-based compensation  $3,072   $763   $6,236   $2,680 

The Company recognized stock-based compensation expense for services in lieu of cash payments to certain consultants, including expenses for both shares issued and stock option awards granted, in the following expense categories of its consolidated statements of operations (in thousands):

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Research and development  $
-
   $
-
   $6   $
-
 
Selling and marketing   
-
    
-
    10    
-
 
General and administrative   
-
    2    2    21 
Total stock-based compensation  $
-
   $2   $18   $21